Mereo BioPharma Group (MREO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.76

1.21%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Revenue	10.00M	1.51M	36.46M	393.00K	-122.00K	-	-3.29M	-
Cost of Revenue	2.57M	936.00K	17.91M	16.35M	23.61M	22.70M	34.61M	24.56M
Gross Profit	7.43M	571.00K	18.56M	-15.95M	-23.73M	-22.70M	-37.89M	-24.56M
Operating Income	-28.42M	-43.57M	-20.94M	-37.57M	-39.52M	-35.21M	-45.30M	-36.18M
Interest Income	2.13M	696.00K	1K	44.00K	377.00K	306.83K	826.86K	195.14K
Pretax Income	-30.00M	-36.09M	14.24M	-166.45M	-41.12M	-37.31M	-46.95M	-33.72M
Net Income	-29.47M	-34.20M	12.72M	-163.63M	-34.84M	-32.03M	-38.80M	-28.39M
Selling & General & Admin	18.42M	19.54M	15.93M	21.22M	15.91M	12.50M	10.70M	11.62M
Research & Development	17.42M	24.96M	23.56M	-16.35M	-23.61M	22.70M	34.61M	24.56M
Other Expenses	-	811.00K	-	-	-	-	-293.33K	-
Operating Expenses	35.84M	44.51M	39.49M	21.22M	15.91M	12.50M	10.70M	11.62M
Interest Expense	2.88M	3.36M	4.00M	6.38M	3.50M	2.36M	1.09M	179.76K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-
Cost & Expenses	38.42M	43.57M	57.40M	37.57M	39.52M	35.21M	45.30M	36.18M
Income Tax	-532.00K	-1.90M	1.52M	-2.82M	-6.27M	-5.28M	-8.15M	-5.33M
Shares Outstanding (Basic)	659.45M	603.20M	527.82M	337.72M	89.34M	71.14M	69.01M	44.79M
Shares Outstanding (Diluted)	659.45M	603.20M	555.28M	338.95M	89.42M	71.14M	69.01M	44.79M
EPS (Basic)	-0.04	-0.06	0.02	-0.48	-0.39	-0.45	-0.56	-0.63
EPS (Diluted)	-0.04	-0.06	0.02	-0.48	-0.39	-0.45	-0.56	-0.63
EBITDA	-26.06M	-42.06M	-5.00M	-37.52M	-37.56M	-34.86M	-44.44M	-38.41M
Depreciation & Amortization	1.06M	1.51M	866.47K	44.00K	1.95M	37.80K	36.08K	32.94K